Study of Surgical Practices in Patient With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA, ALPROLIX)
Latest Information Update: 11 Dec 2023
At a glance
- Drugs Efmoroctocog alfa (Primary) ; Eftrenonacog alfa (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Therapeutic Use
- Acronyms CHALE
Most Recent Events
- 11 Dec 2023 New trial record